日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Role of Neutrophil Extracellular Traps in Atherosclerosis: From the Molecular to the Clinical Level

中性粒细胞胞外陷阱在动脉粥样硬化中的作用:从分子到临床层面

Yuan, Yongfang; Sun, Changxin; Liu, Xinyi; Hu, Lanqing; Wang, Zeping; Li, Xiaoya; Zhang, Jingyi; Li, Dexiu; Zhang, Xiaonan; Wu, Min; Liu, Longtao

Combination of Polydatin and Hawthorn Leave Flavonoids Ameliorate Atherosclerotic Plaque Vulnerability in ApoE(-/-) Mice by Regulating Ferroptosis via the Nrf2/HO-1/GPX4 Axis.

白藜芦醇苷和山楂叶黄酮的组合通过 Nrf2/HO-1/GPX4 轴调节铁死亡,从而改善 ApoE(-/-) 小鼠的动脉粥样硬化斑块脆弱性

Chen Jiye, Zhang Xiaonan, Sun Changxin, Wang Zeping, Li Xiaoya, Hu Lanqing, Yuan Yongfang, Wu Min, Liu Longtao

Triglyceride-glucose index's link to cardiovascular outcomes post-percutaneous coronary intervention in China: a meta-analysis

中国经皮冠状动脉介入治疗后,甘油三酯-葡萄糖指数与心血管结局的关系:一项荟萃分析

Sun, ChangXin; Hu, LanQing; Li, XiaoYa; Zhang, XiaoNan; Chen, JiYe; Li, DeXiu; Zhang, JingYi; Liu, LongTao; Wu, Min

Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview

芍药苷对心血管疾病的保护作用:药理学和机制概述

Li, Xiaoya; Sun, Changxin; Zhang, Jingyi; Hu, Lanqing; Yu, Zongliang; Zhang, Xiaonan; Wang, Zeping; Chen, Jiye; Wu, Min; Liu, Longtao

Targets of statins intervention in LDL-C metabolism: Gut microbiota

他汀类药物干预低密度脂蛋白胆固醇代谢的靶点:肠道菌群

Sun, ChangXin; Wang, ZePing; Hu, LanQing; Zhang, XiaoNan; Chen, JiYe; Yu, ZongLiang; Liu, LongTao; Wu, Min

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview

芍药酚治疗动脉粥样硬化性心血管疾病:药理学和机制概述

Wu, Min; Yu, Zongliang; Li, Xiaoya; Zhang, Xiaonan; Wang, Songzi; Yang, Shengjie; Hu, Lanqing; Liu, Longtao